TECHNIA AB

Truly Labs AB

CT technology for when the inside matters

ZEISS METROTOM 1 now at #HandsOnMetrology.

Ingrid Lönnstedt: ”The confidence interval and its width”

Always keep an eye on the width of your and others’ confidence intervals, writes Ingrid Lönnstedt in a science column.

Moderna develops mRNA vaccine against norovirus

A highly anticipated vaccine is in late clinical evaluation and could be ready for approval within a couple of years. The target is the norovirus, often called ...

Webinar: Automate your processes

Free ZEISS webinar on January 30th, 2025.

Quality Assurance for the Highest Medical Standards

Metrology Solutions for Medical Components.

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Copenhagen (2026)

Merck Life Science A/S

Meribel Pharma Solna

Mercodia AB

The First Multi-Technology System from ZEISS

Microscope and measuring machine in one.

Medicon Valley Alliance

WuXi Biologics Germany GmbH

Lungforskningsbolag kan andas ut efter fulltecknad nyemission

Medicinteknikbolaget Pexa har beslutat att upprätta kontrollbalansräkning – men genomför också en fullt garanterad företrädesemission för att återupprätta sitt aktiekapital.

Non-destructive testing and assembly control

Assess complete assembly.

Final assembly inspection of medical plastics

Technical paper by ZEISS Medical Industry Solutions.

Life science trends 2025 – The economy

Upcoming patent expirations are driving pharmaceutical companies to acquire in 2025. In Sweden, we may be on our way to brighter times and fewer bankruptcies. T...

New drug to simplify treatment of hemophilia

A new type of treatment for hemophilia, which only needs to be administered every two months, has been approved by the U.S. Food and Drug Administration (FDA).

Brittiska regeringen vill fasa ut djurförsök

Den brittiska labourregeringen har presenterat en plan för hur djurförsöken stegvis ska fasas ut.

Partial court victory for entrepreneur who lost his company

Swedish life science entrepreneur Mikael Kubista has won the first round against a law firm that he, along with other co-owners, sued for negligent advice in co...

Han är ny vd för Atrogi – ska ta obesitaskandidat till nästa fas

Det svenska bioteknikbolaget Atrogi, som utvecklar en oral kandidat mot obesitas, har utsett Paul Little till ny vd med omedelbar verkan.

The New Precise Magazine is Available Now

Download the new issue.

FDA approves new cystic fibrosis therapy

A new treatment for cystic fibrosis has been approved by the U.S. Food and Drug Administration (FDA).